| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |